Clinical Trial Update: Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing capecitabine alone versus docetaxel plus capecitabine as first-line chemotherapy for metastatic breast cancer; the trial status is unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Carcinoma, Invasive Ductal, Breast | Phase 3 | Status: UNKNOWN